Acne Vulgaris Guide 2026: Evidence, Options, and Safety

This 2026 guide to acne vulgaris explains which treatments have strong evidence, which options are conditional, and what safety steps matter. Acne vulgaris is an inflammatory disorder of hair follicles and oil glands that causes blackheads, pimples, and deep cysts.

Teenagers carry the greatest burden, but it affects all ages. An NIH review citing the Global Burden of Disease Study estimates about 9.4% prevalence worldwide and about 85% of ages 12-25 affected at some point. Readers can use this guide to compare options, weigh limits, and plan a clinician visit.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Which treatments have the strongest evidence?
When are other options considered?
Should you still use benzoyl peroxide?
Why does isotretinoin need extra safety steps?
Does diet affect acne?

Which treatments have the strongest evidence?

The American Academy of Dermatology 2024 guideline strongly recommends topical benzoyl peroxide, topical retinoids, topical antibiotics in fixed-dose combinations, oral doxycycline, and oral isotretinoin for severe, scarring or treatment-resistant disease, as summarized by Dermatology Times coverage of the recommendations. Strong means benefits clearly outweigh harms for most patients.

Those options cover different needs in one plan. Topical agents target surface disease, oral doxycycline adds systemic treatment, and isotretinoin is reserved for severe, scarring or treatment-resistant disease.

topical benzoyl peroxide
topical retinoid
topical antibiotic in fixed-dose combination
oral doxycycline
oral isotretinoin for severe, scarring or treatment-resistant disease

When are other options considered?

The same Academy guideline only conditionally recommends topical clascoterone, salicylic acid, azelaic acid, oral minocycline and sarecycline, and combined oral contraceptives and spironolactone for women. Managed Healthcare Executive reporting on the guideline notes concern that high cost will limit equitable access. Conditional means benefit is less certain or access may narrow who can use it.

Two newer drugs fill narrower gaps. Clascoterone 1% is the first FDA-approved topical addressing hormonal acne in both men and women, according to the guideline co-chair via MDedge. Sarecycline is the only FDA-approved narrow-spectrum oral acne antibiotic, with potential for less resistance, GI upset and vestibular effects than doxycycline or minocycline.

Should you still use benzoyl peroxide?

Benzene concerns do not require discarding all benzoyl peroxide. FDA testing of 95 products in March 2025 found over 90% had undetectable or low benzene and only six lots were recalled, according to Dermatology Advisor summary of FDA testing.

FDA stated decades of daily use carries very low cancer risk. The practical step is selective, not wholesale avoidance. Check your lot against recall lists, store products as directed, replace old or heat-exposed tubes, and ask a pharmacist about a replacement lot when needed.

Why does isotretinoin need extra safety steps?

Isotretinoin is teratogenic and contraindicated in pregnancy under FDA iPLEDGE REMS since 2006, which requires testing and contraception. Dry skin, eyes and lips are most common, and in Feb 2026 FDA eased burden by permitting at-home pregnancy tests and ending monthly qualification for those who cannot become pregnant, as reported by Healio report on the FDA change.

The change lowers logistical burden without removing pregnancy protection. Readers who discuss it with a clinician should expect clear checks.

confirm pregnancy potential and testing schedule
use contraception as directed when required
report dryness, eye irritation, or lip cracking early
confirm whether monthly qualification still applies to you

Does diet affect acne?

A systematic NIH review found high glycemic-index and high glycemic-load intake positively associated with acne onset and severity, supported by randomized trials. Dairy intake was only weakly and inconsistently associated by sex and ethnicity. Diet influences risk but does not alone prove causation.

The limit matters for decisions. A lower glycemic-load pattern may help some people, but strict dairy elimination alone is unlikely to control moderate or severe disease. Track breakouts alongside treatment, sleep, and menstrual cycles, then review the pattern with a clinician.